{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T18:10:09Z","timestamp":1749924609882,"version":"3.41.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,14]]},"DOI":"10.7759\/cureus.86010","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T17:38:29Z","timestamp":1749922709000},"source":"Crossref","is-referenced-by-count":0,"title":["Unmasking the Silent Culprit: Gastric Neuroendocrine Tumor in the Setting of Iron Deficiency Anemia"],"prefix":"10.7759","author":[{"given":"Ashley","family":"Serjilus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison M","family":"Bush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier N","family":"De Luca-Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan J","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie L","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin IM","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003, 97:934-59. 10.1002\/cncr.11105","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000167862.52309.7d","article-title":"Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type","volume":"242","author":"Borch K","year":"2005","unstructured":"Borch K, Ahr\u00e9n B, Ahlman H, Falkmer S, Gran\u00e9rus G, Grimelius L. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg. 2005, 242:64-73. 10.1097\/01.sla.0000167862.52309.7d","journal-title":"Ann Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181ebb168","article-title":"NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas","volume":"39","author":"Kulke MH","year":"2010","unstructured":"Kulke MH, Anthony LB, Bushnell DL, et al.. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010, 39:735-52. 10.1097\/MPA.0b013e3181ebb168","journal-title":"Pancreas"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi G","year":"2006","unstructured":"Rindi G, Kl\u00f6ppel G, Alhman H, et al.. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006, 449:395-401. 10.1007\/s00428-006-0250-1","journal-title":"Virchows Arch"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin IM","year":"2008","unstructured":"Modlin IM, Oberg K, Chung DC, et al.. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008, 9:61-72. 10.1016\/S1470-2045(07)70410-2","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.1535","article-title":"Chromogranin A: is it a useful marker of neuroendocrine tumors?","volume":"25","author":"Campana D","year":"2007","unstructured":"Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, Tomassetti P. Chromogranin A: is it a useful marker of neuroendocrine tumors?. J Clin Oncol. 2007, 25:1967-73. 10.1200\/JCO.2006.10.1535","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi M","year":"2016","unstructured":"Falconi M, Eriksson B, Kaltsas G, et al.. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016, 103:153-71. 10.1159\/000443171","journal-title":"Neuroendocrinology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300169-unmasking-the-silent-culprit-gastric-neuroendocrine-tumor-in-the-setting-of-iron-deficiency-anemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T17:38:30Z","timestamp":1749922710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300169-unmasking-the-silent-culprit-gastric-neuroendocrine-tumor-in-the-setting-of-iron-deficiency-anemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.86010","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,14]]}}}